LGM
APTO

Logos Global Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Logos Global Management’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,667
Closed -$4.73M – 67
2020
Q2 		$4.73M Buy
+1,667
New +$5.38M 0.95% 31
2020
Q1 		– Sell
-1,164
Closed -$2.97M – 56
2019
Q4 		$2.97M Buy
+1,164
New +$1.52M 0.73% 31

Other funds holding APTO

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Logos Global Management's APTO Position: Q3 2020 in Review

Logos Global Management sold out of Aptose Biosciences, Inc. (APTO) in Q3 2020, closing a stake of 1,667 shares — an estimated $4.73M sold.

Logos Global Management first reported a position in APTO in Q4 2019 and held it in 2 quarters. The position peaked at $4.73M in Q2 2020. 64 funds tracked by Wall St. Rank hold APTO as of Q3 2020.

  • Logos Global Management reported no remaining Aptose Biosciences, Inc. position as of Q3 2020 after selling out during the quarter.
  • Logos Global Management sold 1,667 Aptose Biosciences, Inc. shares in Q3 2020, an estimated $4.73M.
  • Logos Global Management first reported a position in Aptose Biosciences, Inc. in Q4 2019 and held it in 2 quarters.
  • Logos Global Management's Aptose Biosciences, Inc. position peaked at $4.73M in Q2 2020.
  • 64 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2020.

Based on Logos Global Management's 13F filing for Q3 2020, filed 16 Nov 2020.